Type 1 diabetes and gastroparesis: Diagnosis and treatment

Current Gastroenterology Reports

Volumn 9, Issue 4, 2007, Pages 261-269

  Hasler, William L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BETHANECHOL; BOTULINUM TOXIN; BUSPIRONE; CISAPRIDE; CLARITHROMYCIN; CLONIDINE; DOMPERIDONE; ERYTHROMYCIN; GHRELIN; GINGER EXTRACT; GLUCOSE; MACROLIDE; METOCLOPRAMIDE; MIRTAZAPINE; MITEMCINAL; MOSAPRIDE CITRATE; NITRATE; PHENOTHIAZINE; PROCHLORPERAZINE; PROKINETIC AGENT; PYRIDOSTIGMINE; RENZAPRIDE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TEGASEROD; THIETHYLPERAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ACUPUNCTURE; AGITATION; AMENORRHEA; ANTIEMETIC ACTIVITY; ANXIETY DISORDER; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DEVICE REMOVAL; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIAPHORESIS; DIET THERAPY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSTONIA; ELECTROGASTROGRAPHY; ELECTROSTIMULATION THERAPY; ENDOSCOPIC SURGERY; ENTERIC FEEDING; FATALITY; FATIGUE; GALACTORRHEA; GASTROENTEROSTOMY; GASTROINTESTINAL ENDOSCOPY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEATH; HUMAN; HYPERPROLACTINEMIA; HYPOTENSION; IMPOTENCE; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; JEJUNOSTOMY; LONG TERM CARE; MENTAL DISEASE; MUSCLE SPASM; NAUSEA AND VOMITING; PANCREAS TRANSPLANTATION; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PYLOROPLASTY; REVIEW; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER; SOMATIZATION; STOMACH EMPTYING; STOMACH OBSTRUCTION; STOMACH PARESIS; STOMACH SCINTISCANNING; TARDIVE DYSKINESIA; TOTAL STOMACH RESECTION; TREATMENT INDICATION; URINARY URGENCY;

DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; ELECTRIC STIMULATION THERAPY; GASTRECTOMY; GASTROPARESIS; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 34848873484     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0029-9     Document Type: Review

References (50)

1. Soykan, I, Sivri B, Saroseik I, et al.: Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998, 43:2398-2404.
2. Cutts TF, Luo J, Starkebaum W, et al.: Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and longterm health care benefits? Neurogastroenterol Motil 2005, 17:35-43.
3. Hoogerwerf WA, Pasricha PJ, Kalloo AN, Schuster MM: Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999, 94:1029-1033.
4. Bytzer P, Talley NJ, Leemon M, et al.: Prevalence of gastrointestinal symptoms associated with diabetes mellitus. Arch Intern Med 2001, 161:1989-1996.
5. Eisenberg B, Murata GH, Tzamaloukas AH, et al.: Gastroparesis in diabetics on chronic dialysis: clinical and laboratory associations and predictive features. Nephron 1995, 70:296-300.
6. Hasler W, Coleski R, Chey WD, et al.: Selective intragastric PH profile impairment in diabetic vs. idiopathic gastroparesis: relation to degree of gastric stasis [abstract]. Neurogastroenterol Motil 2006, 18:741.
7. Gaddipati KV, Simonian HP, Kresge KM, et al.: Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci 2006, 51:1339-1346.
8. Jones KL, Russo A, Berry MK, et al.: A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 2002, 113:449-455.
9. Ejskjaer NT, Bradley JL, Buxton-Thomas MS, et al.: Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999, 16:488-495.
10. Jackson MW, Gordon TP, Waterman SA: Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology 2004, 126:819-828.
11. He CL, Soffer EE, Ferris CD, et al.: Loss of interstitial cells of Cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001, 121:427-434.
12. Forster J, Damjanov I, Lin Z, et al.: Absence of interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005, 9:102-108.
13. Vittal H, Farrugia G, Pehlivanov ND, et al.: Neuropathological and genomic changes in the stomach of patients with human diabetic gastroparesis [abstract]. Gastroenterology 2006, 130:245.
14. Horvath VJ, Vittal H, Lorincz A, et al.: Reduced stem cell factor links smooth myopathy and loss of interstitial cells of Cajal in murine diabetic gastroparesis. Gastroenterology 2006, 130:759-770.
15. Samsom M, Salet GA, Roelofs JM, et al.: Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci 1995, 40:2037-2042.
16. Rathmann W, Erick P, Frieling T, Gries FA: Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care 1991, 14:1086-1089.
17. Revicki DA, Rentz AM, Dubois D, et al.: Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003, 18:141-150.
18. de la Loge C, Trudeau E, Marquis P, et al.: Cross-cultural development and validation of a self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res 2004, 13:1751-1762.
19. House A, Champion MC, Chamberlain M: National survey of radionuclide gastric emptying studies. Can J Gastroenterol 1997, 11:317-321.
20. Tougas G, Eaker EY, Abell TL, et al.: Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000, 95:1456-1462.
21. Guo JP, Maurer AH, Fisher RS, Parkman HP: Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001, 46:24-29.
22. Galil MA, Critchley M, Mackie CR: Isotope gastric emptying tests in clinical practice: expectation, outcome, and utility. Gut 1993, 34:916-919.
23. Kuo B, McCallum RW, Koch KL, et al.: SmartPill, a novel ambulatory diagnostic test for measuring gastric emptying in health and disease [abstract]. Gastroenterology 2006, 130:M2205.
24. Camilleri M, Malagelada J-R: Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984, 14:420-427.
25. Chen JD, Lin Z, Pan J, McCallum RW. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci 1996, 41:1538-1545.
26. Koch KL, Stern RM, Stewart WR, Vasey MW: Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 1989, 84:1069-1075.
27. Abell TL, Bernstein RK, Cutts T, et al.: Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006, 18:263-283.
28. Sturm A, Holtmann G, Goebell H, Gerken G: Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 1999, 60:422-427.
29. Parkman HP, Hasler WL, Fisher RS: American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004, 127:1592-1622.
30. Ganzini L, Casey DE, Hoffman WF, McCall AL: The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 1993, 153:1469-1475.
31. Ray WA, Murray KT, Meredith S, et al.: Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004, 351:1089-1096.
32. Tougas G, Chen Y, Luo D, et al.: Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms [abstract]. Gastroenterology 2003, 124:A54.
33. Stacher G, Schernthaner G, Francesconi M, et al.: Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial. J Clin Endocrinol Metab 1999, 84:2357-2362.
34. Lossos IS, Mevorach D, Oren R: Thiethylperazine treatment of gastroparesis diabeticorum. Ann Pharmacother 1992, 26:1016.
35. Prakash C, Lustman PJ, Freedland KE, Clouse RE: Tricyclic antidepressants for functional nausea and vomiting. Dig Dis Sci 1998, 43:1951-1956.
36. Sawhney MS, Prakash C, Lustman PJ, Clouse RE: Tricyclic antidepressants for persistent or recurrent vomiting in diabetic persons [abstract]. Gastroenterology 2001, 120:A243.
37. Kim SW, Shin IS, Kim JM, et al.: Mirtazepine for severe gastroparesis unresponsive to conventional prokinetic treatment. Psychosomatics 2006, 47:440-442.
38. Wang L: Clinical observation on acupuncture treatment in 35 cases of diabetic gastroparesis. J Tradit Cbin Med 2004, 24:163-165.
39. Lacy BE, Crowell MD, Schettler-Duncan A, et al.: The treatment of diabetic gastroparesis with botulinum. toxin injection into the pylorus. Diabetes Care 2004, 27:2341-2347.
40. Bromer MQ, Friedenberg F, Miller LS, et al.: Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005, 61:833-839.
41. Coleski R, Hasler W: Clinical and gastric functional predictors of symptom response to pyloric injection of botulinum toxin in patients with gastroparesis [abstract]. Neurogastroenterol Motil 2005, 17:628.
42. McCallum RW, Chen JD, Lin Z, et al.: Gastric pacing improves emptying and symptoms in patients with gastro paresis. Gastroenterology 1998, 114:456-461.
43. Abell TL, Van Cutsem E, Abrahamsson H, et al.: Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 2002, 66:204-212.
44. van der Voort IR, Becker JC, Dietl KH, et al.: Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis. Exp Clin Endocrinol Diab 2005, 113:38-42.
45. Abell, T, McCallum, R, Hocking, M, et al.: Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003, 125:421-428.
46. Watkins PJ, Buxton-Thomas MS, Howard ER: Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med 2003, 20:58-63.
47. Cashion AK, Holmes SL, Hathaway DK, Gaber AO: Gastroparesis following kidney/pancreas transplant. Clin Transplant 2004, 18:306-311.
48. Fontana RJ, Barnett JL: Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol 1996, 91:2174-2178.
49. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 1989, 84:868-872.
50. Murray CD, Martin NM, Patterson M, et al.: Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005, 54:1693-1698.